Cancer Incidence and Mortality Tables

About Michigan Cancer Data

Cancer incidence data were collected by the Michigan Cancer Surveillance Program, which participates in the National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC). The Michigan incidence statistics on this site spans through 2007, and includes mortality data up to 2008. Statistics for national comparisons are provided as well, and orignates from the Surveillance Epidemiology and End Results (SEER) program.

Cancer incidence and mortality statistics for Michigan counties and local health department districts can be accessed through the Community Health Information Cancer Site.

Selected high points concerning these data are provided below:

	Cancer Incidence Rate Decreases Slightly in 2007 The cancer age-adjusted incidence rate in 2007 was 488.4 per 100,000 residents, slightly lower than the 2006 age-adjusted rate of 493.5. The rate for 2007 remains below the peak incidence rate for Michigan of 551.6 in 1992, and highlights the continued stability in the overall cancer incidence rate for Michigan since 1994. (See Invasive Cancer Incidence and Mortality Trends.)
	Cancer Mortality Rates Relatively Stable The rates for cancer mortality have been fairly stable since the 1990's in Michigan. The age-adjusted 2008 cancer mortality rate for Michigan decreased to 185.5 per 100,000 residents compared to a rate of 202.5 in 2000. The mortality rate has been stable to declining since the early 1990's after a long history of rising rates (See Invasive Cancer Incidence and Mortality Trends.)
	Frequency of Cancer is Stable or Declining for Most Major Primary Organ Sites Lung cancer incidence rates have held relatively stable since 1995 while breast, colorectal and prostate cancer incidence have shown a decline in recent years. At the same time, mortality rates for the leading sites have held relatively stable through 2008.
	Cancer Incidence Rates are Declining for Males and Females Declines in cancer incidence rates are evident during the 1990's for some of the leading cancer sites for both sexes. The drop in incidence has been more evident among males, with the most marked decline being prostate cancer. Male lung cancer rates declined throughout the 1990's while increasing slightly for females. Lung cancer remains much more common among males than among females. (See Cancer Incidence Trends.)
	The Trend Toward Earlier Diagnosis is Continuing The pattern of earlier stage at diagnosis continued into 2007. Of the cancer cases diagnosed during 2007, 53.6 percent had localized or in situ disease. This is especially apparent for breast and prostate cancer cases with corresponding declines in late stage diagnoses. Staging tables are also presented for each of the leading sites. (See Cancer Incidence by Stage at Diagnosis.)
	Cancer Rates by Race Show Consistent Patterns Total cancer incidence rates for black and white females are comparable, while cancer incidence rates for all cancers are higher for black males than for white males. This is due, in particular, to higher cancer incidence for black males between the ages of 50 and 79. Breast cancer rates are slightly higher for white than for black women, while lung and colorectal cancers tend to be higher among black women. For males, colorectal cancer is marginally higher among blacks, while lung and prostate cancer rates tend to be markedly higher than for white males. (See Three-year Age-Adjusted Cancer Incidence Rates, by Race, Sex and County. )
	Detailed Primary Site/Type Data Cancer incidence and mortality increase progressively with age for all cancer sites. Relative to cancer mortality, lung cancer is the dominant cancer primary site across all ages, reflecting the severity of this diagnosis. Cancer incidence by site is more varied relative to the age of the patient. Breast and cancers across the genitourinary organs are the most common for patients under 50. Cancers of the prostate and the lung are most frequent for ages over 50. At ages 50 through 74 prostate cancer is the most frequent followed by lung and breast cancer. Over 75 years of age, the four leading cancer sites are lung, prostate, colon and breast, respectively.
	Survival Data Relative survival rates for Michigan residents and SEER comparisons are shown for leading primary sites by race, gender and stage at diagnosis for one, three, and five-year survival periods. Lung cancer survival rates are the lowest at all stages, for both white and black Michigan residents. (See Five-year Lung Cancer Relative Survival Rates, 1985-1998.) Prostate cancer survival rates have shown the most dramatic improvement over the past two decades, reaching 100.0 percent for cases diagnosed in localized / regional stage. (See Five-year Prostate Cancer Relative Survival Rates, 1985-1998.) Breast cancer survival rates have also improved, although survival for black females continues to lag slightly behind white female rates. (See Five-year Breast Cancer Relative Survival Rates, 1985-1998.) Survival for colorectal cancer has remained generally constant over time, with localized survival rates about twenty percent higher than those diagnosed at regional stage. Rates are similar for white and black populations. (See Five-year Colorectal Cancer Survival Rates, 1985-1998.)